Is Artemis Medicare Services a Good Buy After Its Q1 FY27 Results?

The Artemis Medicare Services share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Artemis Medicare Services is a Gurugram-based multi-specialty hospital chain, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 293 crore, up 11.8% year on year, while profit after tax came in at Rs 31 crore, up 48.3% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Artemis Medicare Services share price from here.

This piece works through the quarter's financial highlights, the business factors behind the numbers, where the Artemis Medicare Services share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Artemis Medicare Services Q1 FY27 Financial Highlights

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 293 crore	Rs 262 crore	11.8%
EBITDA	Rs 62 crore	Rs 48 crore	27.9%
Operating Margin	21.5%	18.9%	NA
Profit Before Tax	Rs 43 crore	Rs 30 crore	43.1%
Net Profit / (Loss)	Rs 31 crore	Rs 21 crore	48.3%

Artemis Medicare Services Q1 FY27 Performance Analysis

Check Artemis Medicare Services Fundamentals on Univest Screener

Revenue growth of 11.8% for the quarter came from steady demand across the company's core business, keeping the topline trend intact for the hospital and healthcare services sector.

The bigger story is on profitability. PAT grew 48% to Rs 31 crore, comfortably ahead of revenue growth, which points to margin expansion or a favourable base effect. This is the kind of quarter that supports the premium the Artemis Medicare Services share price already commands, though investors should check whether the growth is repeatable or was helped by one-off factors.

On a sequential basis, revenue moved up 2.0% sequentially from Rs 287 crore in the March 2026 quarter and net profit moved up 3.8% sequentially from Rs 30 crore in the prior quarter, giving a fuller picture of the trend behind the Artemis Medicare Services share price than the year on year comparison alone.

Key Business Factors in Q1 FY27

Revenue Trend

Artemis Medicare Services' revenue grew 11.8% year on year this quarter, taking the quarterly base to Rs 293 crore in a hospital and healthcare services business that remains sensitive to demand and pricing cycles that ultimately feed through to the Artemis Medicare Services share price.

Margin Movement

EBITDA rose 27.9% to Rs 62 crore, and operating margin moved to 21.5% from 18.9% a year earlier, a sign that cost control or pricing held up during the quarter.

Balance Sheet Position

Artemis Medicare Services carries a low debt-to-equity ratio of 0.28, giving it a conservative balance sheet heading into the rest of FY27.

Valuation Context

The stock trades at a PE of 47.8x, below the industry average of 67.5x, which is worth factoring into any read of whether the Artemis Medicare Services share price is expensive or reasonably priced.

Dividend Details

No interim dividend was declared alongside Artemis Medicare Services' Q1 FY27 results. The stock currently carries a trailing dividend yield of 0.13%, based on dividends paid over the last year. Investors tracking the Artemis Medicare Services share price for income should watch the company's announcements around its next annual results for any dividend decision.

Artemis Medicare Services Share Price Outlook for FY27

The Q1 FY27 print sets a reasonably high bar for the rest of the year. If Artemis Medicare Services can sustain this pace of revenue and profit growth, the current valuation gets easier to justify. The main swing factor is whether this quarter's momentum reflects a durable trend or a favourable one-off, something the next two quarters should clarify.

For the Artemis Medicare Services share price to hold its current premium through FY27, the company will likely need to keep posting growth at or near this quarter's pace, since any slowdown would put pressure on a stock priced for continued strength.

Artemis Medicare Services Stock Performance

Download the Univest iOS App or Univest Android App to track Artemis Medicare Services' live share price and get daily stock updates.

The Artemis Medicare Services share price was trading around Rs 345 as results season played out in late August 2026, roughly 1.3% below its 52-week high of Rs 350 and well above its 52-week low of Rs 203.

The Artemis Medicare Services share price has room to re-rate further if the growth shown this quarter continues, though much of the good news may already be reflected in the stock near current levels. On profitability ratios, the company reports a return on equity of 11.09% and a book value of around Rs 55 per share, both useful reference points when judging whether the current price is reasonable.

Key Risks

Sector and Demand Risk

As a hospital and healthcare services business, Artemis Medicare Services' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Artemis Medicare Services share price well before the next result.

Execution Risk

Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

Conclusion

Artemis Medicare Services' Q1 FY27 results were genuinely strong, with revenue at Rs 293 crore and PAT up 48% to Rs 31 crore. That said, at a PE of 47.8x, the Artemis Medicare Services share price is not inexpensive, so this looks like a quality business trading at a full price rather than a bargain. Existing investors have little to worry about from this print, while new investors asking whether Artemis Medicare Services is a good buy should weigh the strong quarter against the valuation before adding at current levels.

Frequently Asked Questions on Artemis Medicare Services Q1 FY27 Results

What were Artemis Medicare Services' Q1 FY27 results?

Ans. Artemis Medicare Services reported Q1 FY27 revenue of Rs 293 crore, up 11.8% year on year, and PAT of Rs 31 crore, up 48.3% year on year.

Is Artemis Medicare Services a good buy after its Q1 FY27 results?

Ans. Artemis Medicare Services' core numbers improved this quarter, though at a PE of 47.8x the stock is not inexpensive, so this suits investors comfortable paying up for quality. Investors should form their own view based on their own risk appetite and time horizon.

What is the Artemis Medicare Services share price today?

Ans. The Artemis Medicare Services share price was trading around Rs 345 in late August 2026, about 1.3% below its 52-week high of Rs 350 and well above its 52-week low of Rs 203.

What is Artemis Medicare Services' revenue and profit for Q1 FY27?

Ans. Artemis Medicare Services reported revenue of Rs 293 crore and a net profit of Rs 31 crore for the quarter ended June 30, 2026.

Did Artemis Medicare Services declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Artemis Medicare Services' Q1 FY27 results. Investors should track the company's next annual results for any dividend announcement.

What is Artemis Medicare Services' PE ratio and is it expensive?

Ans. The Artemis Medicare Services share price trades at a trailing PE of 47.8x, against an industry average of 67.5x. Investors should compare this with the company's growth rate before judging value.

What are the key risks for Artemis Medicare Services investors right now?

Ans. As a hospital and healthcare services business, Artemis Medicare Services' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Artemis Medicare Services share price well before the next result. Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

What is Artemis Medicare Services' promoter shareholding?

Ans. Promoter shareholding data for Artemis Medicare Services was not fully available for this quarter and should be checked on the company's official filings.